Tatiana V. Grigoreva
Lead Expert in Development and Clinical Support, OncoAtlas LLC; Researcher, Laboratory for Applied Genomic Technologies, Institute for personalized oncology, I.M. Sechenov First Moscow State Medical University, ORCID: https://orcid.org/0000-0001-9054-1481
Статьи автора:
PATHWAY DIRECTED MECHANISMS OF ANTI-EGFR RESISTANCE IN COLORECTAL CANCER (REVIEW)
Background: Targeting the epidermal growth factor receptor (EGFR) with cetuximab or panitumumab (anti-EGFR MAb) has been historically reserved ...
